Asahi Glass and Dsm Biologics team up in biopharmaceuticals

Asahi Glass Co. announced on 19 July that it has signed an exclusive agency agreement to broker consigned production of medical proteins with drug makers on behalf of DSM Biologics, a business unit of…

Asahi Glass Co. announced on 19 July that it has signed an exclusive agency agreement to broker consigned production of medical proteins with drug makers on behalf of DSM Biologics, a business unit of Dutch chemical group DSM. Under the agreement effective from this month, Asahi Glass will arrange for DSM Biologics to supply antibody and vaccine ingredients. The agreement gives DSM Biologics a way to expand its business in Japan, the world“s second-largest market for its products, while enabling Asahi Glass to broaden its own business activities in protein-based medicines. The two companies see the business generating domestic sales of nearly US$ 80 million in 2005.